A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function.
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Dendritic cells are rare haematopoietic cells that reside in a number of organs and tissues. By capturing, processing and presenting antigens to T cells, dendritic cells are essential for immune surveillance and the regulation of specific immunity. Several members of the tumour necrosis factor receptor (TNFR) superfamily are integral to the regulation of the immune response. These structurally related proteins modulate cellular functions ranging from proliferation and differentiation to inflammation and cell survival or deaths. The functional activity of dendritic cells is greatly increased by signalling through the TNFR family member CD40. Here we report the characterization of RANK (for receptor activator of NF-kappaB), a new member of the TNFR family derived from dendritic cells, and the isolation of a RANK ligand (RANKL) by direct expression screening. RANKL augments the ability of dendritic cells to stimulate naive T-cell proliferation in a mixed lymphocyte reaction, and increases the survival of RANK+ T cells generated with interleukin-4 and transforming growth factor (TGF)-beta. Thus RANK and RANKL seem to be important regulators of interactions between T cells and dendritic cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The receptor that mediates all known activities for RANKL is called receptor activator of nuclear factor B (RANK) (Figs. 1 and 2).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [41]
Citations
Cites
Basic local alignment search tool
Altschul, S. F., Gish, W., Miller, W., Myers, E. W., & Lipman, D. J. (1990) · Journal of Molecular Biology · doi:10.1006/jmbi.1990.9999 · Cited by 98,669
Function and Activation of NF-kappaB in the Immune System
Baeuerle, P. A., & Henkel, T. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.001041 · Cited by 4,745
The Dendritic Cell System and its Role in Immunogenicity
Steinman, R. M. (1991) · Annual Review of Immunology · doi:10.1146/annurev.iy.09.040191.001415 · Cited by 4,658
Cella, M., Scheidegger, D., Palmer-Lehmann, K., Lane, P., Lanzavecchia, A., & Alber, G. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.2.747 · Cited by 1,983
The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death
Smith, C. A., Farrah, T., & Goodwin, R. G. (1994) · Cell · doi:10.1016/0092-8674(94)90372-7 · Cited by 1,887
Activation of human dendritic cells through CD40 cross-linking.
Caux, C., Massacrier, C., Vanbervliet, B., Dubois, B., Van Kooten, C., Durand, I., & Banchereau, J. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.4.1263 · Cited by 1,317
TRAF2-Mediated Activation of NF-κB by TNF Receptor 2 and CD40
Rothe, M., Sarma, V., Dixit, V. M., & Goeddel, D. V. (1995) · Science · doi:10.1126/science.7544915 · Cited by 1,051
Wong, B. R., Rho, J., Arron, J., Robinson, E., Orlinick, J., Chao, M., Kalachikov, S., Cayani, E., Bartlett, F. S., Frankel, W. N., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.40.25190 · Cited by 1,042
Molecular and biological characterization of a murine ligand for CD40
Armitage, R. J., Fanslow, W. C., Strockbine, L., Sato, T. A., Clifford, K. N., Macduff, B. M., Anderson, D. M., Gimpel, S. D., Davis-Smith, T., Maliszewski, C. R., et al. (1992) · Nature · doi:10.1038/357080a0 · Cited by 1,022
Self-citationHerpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor
Yao, Z., Fanslow, W. C., Seldin, M. F., Rousseau, A.-M., Painter, S. L., Comeau, M. R., Cohen, J. I., & Spriggs, M. K. (1995) · Immunity · doi:10.1016/1074-7613(95)90070-5 · Cited by 994
Cited by
Items 401–500 of 1,012
Stimulation of Osteoprotegerin (OPG) Gene Expression by Transforming Growth Factor-β (TGF-β)
Thirunavukkarasu, K., Miles, R. R., Halladay, D. L., Yang, X., Galvin, R. J. S., Chandrasekhar, S., Martin, T. J., & Onyia, J. E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104319200 · Cited by 138
Regulatory Mechanism of Osteoclastogenesis by RANKL and Wnt Signals
Takahashi, N. (2011) · Frontiers in Bioscience · doi:10.2741/3673 · Cited by 131
Factors regulating the growth of metastatic cancer in bone.
Boyce, B. F., Yoneda, T., & Guise, T. A. (1999) · Endocrine-related cancer · doi:10.1677/erc.0.0060333 · Cited by 144
Komine, M., Kukita, A., Kukita, T., Ogata, Y., Hotokebuchi, T., & Kohashi, O. (2001) · Bone · doi:10.1016/s8756-3282(01)00420-3 · Cited by 156
Vitamin D endocrine system and osteoclasts
Takahashi, N., Udagawa, N., & Suda, T. (2014) · BoneKEy Reports · doi:10.1038/bonekey.2013.229 · Cited by 120
Functional expression of receptor activator of nuclear factor κB in Hodgkin disease cell lines
Fiumara, P. F., Snell, V., Li, Y., Mukhopadhyay, A., Younes, M., Gillenwater, A. M., Cabanillas, F., Aggarwal, B. B., & Younes, A. (2001) · Blood · doi:10.1182/blood.v98.9.2784 · Cited by 155
Enhanced RANK ligand expression and responsivity of bone marrow cells in Paget’s disease of bone.
Menaa, C., Reddy, S. V., Kurihara, N., Maeda, H., Anderson, D., Cundy, T., Cornish, J., Singer, F. R., Bruder, J. M., & Roodman, G. D. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9133 · Cited by 154
“(15) have shown that overexpression of RANK can induce NF-κB signaling even in the absence of RANKL.”
BackgroundSelf-citationIndran, I. R., Liang, R. L. Z., Min, T., & Yong, E. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.01.015 · Cited by 154
Immune System Evasion as Hallmark of Melanoma Progression: The Role of Dendritic Cells
Tucci, M., Passarelli, A. M., Mannavola, F., Felici, C., Stucci, L. S., Cives, M., & Silvestris, F. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01148 · Cited by 154
Osteoclast formation and resorption
Lerner, U. H. (2000) · Matrix Biology · doi:10.1016/s0945-053x(00)00052-4 · Cited by 154
Hanada, R., Hanada, T., Sigl, V., Schramek, D., & Penninger, J. M. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0749-z · Cited by 154
Secreted Frizzled-Related Protein-1 Inhibits RANKL-Dependent Osteoclast Formation
Häusler, K. D., Horwood, N. J., Chuman, Y., Fisher, J. L., Ellis, J., Martin, T. J., Rubin, J. S., & Gillespie, M. T. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040807 · Cited by 142
Osteoprotegerin: Multiple partners for multiple functions
Baud’huin, M., Duplomb, L., Teletchea, S., Lamoureux, F., Ruiz-Velasco, C., Maillasson, M., Redini, F., Heymann, M.-F., & Heymann, D. (2013) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2013.06.001 · Cited by 153
“RANKL was initially discovered by two groups working on TNF-related cytokines thanks by its ability to sustain dendritic cell survival (Anderson et al. 1997; Wong et al. 1997).”
BackgroundStructural and Functional Insights of RANKL–RANK Interaction and Signaling
Liu, C., Walter, T. S., Huang, P., Zhang, S., Zhu, X., Wu, Y., Wedderburn, L. R., Tang, P., Owens, R. J., Stuart, D. I., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0904033 · Cited by 136
Vitovski, S., Phillips, J. S., Sayers, J. R., & Croucher, P. I. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706078200 · Cited by 153
Lu, H. ‐., Chen, Y. ‐., Chang, H. ‐., Li, C. ‐., & Kuo, M. Y. ‐. (2006) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.2006.00883.x · Cited by 136
Colucci, S., Brunetti, G., Rizzi, R., Zonno, A., Mori, G., Colaianni, G., Del Prete, D., Faccio, R., Liso, A., Capalbo, S., et al. (2004) · Blood · doi:10.1182/blood-2004-02-0474 · Cited by 146
The role of RANK ligand/osteoprotegerin in rheumatoid arthritis
Geusens, P. (2012) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x12438080 · Cited by 153
Nguyen, L. T., Duncan, G. S., Mirtsos, C., Ng, M. S. W., Speiser, D. E., Shahinian, A., Marino, M. W., Mak, T. W., Ohashi, P. S., & Yeh, W. (1999) · Immunity · doi:10.1016/s1074-7613(00)80113-2 · Cited by 152
Zheng, M., Robbins, P., Xu, J., Huang, L., Wood, D., & Papadimitriou, J. M. (2001) · PubMed · doi:10.14670/hh-16.297 · Cited by 151
Takeuchi, T., Tsuboi, T., Arai, M., & Togari, A. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00591-8 · Cited by 151
Osteoclasts expressing the measles virus nucleocapsid gene display a pagetic phenotype
Kurihara, N., Reddy, S. V., Menaa, C., Anderson, D., & Roodman, G. D. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8489 · Cited by 142
Self-citationRegulatory roles and molecular signaling of TNF family members in osteoclasts
Feng, X. (2005) · Gene · doi:10.1016/j.gene.2005.01.014 · Cited by 152
A novel ubiquitin‐binding protein ZNF216 functioning in muscle atrophy
Hishiya, A., Iemura, S., Natsume, T., Takayama, S.-I. J., Ikeda, K., & Watanabe, K. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7600945 · Cited by 151
RANKL Employs Distinct Binding Modes to Engage RANK and the Osteoprotegerin Decoy Receptor
Nelson, C. A., Warren, J. T., Wang, M. W.-H., Teitelbaum, S. L., & Fremont, D. H. (2012) · Structure · doi:10.1016/j.str.2012.08.030 · Cited by 132
Gao, Y., Shinki, T., Yuasa, T., Kataoka-Enomoto, H., Komori, T., Suda, T., & Yamaguchi, A. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9643 · Cited by 150
Nagasawa, T., Kiji, M., Yashiro, R., Hormdee, D., Lu, H., Kunze, M., Suda, T., Koshy, G., Kobayashi, H., Oda, S., et al. (2007) · Periodontology 2000 · doi:10.1111/j.1600-0757.2006.00185.x · Cited by 150
Karsdal, M. A., Hjorth, P., Henriksen, K., Kirkegaard, T., Nielsen, K. L., Lou, H., Delaissé, J.-M., & Foged, N. T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303905200 · Cited by 137
Alnaeeli, M., Penninger, J. M., & Teng, Y.-T. A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.5.3314 · Cited by 142
Atkins, G. J., Kostakis, P., Vincent, C., Farrugia, A. N., Houchins, J. P., Findlay, D. M., Evdokiou, A., & Zannettino, A. C. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060604 · Cited by 131
Estrogens in rheumatoid arthritis; the immune system and bone
Islander, U., Jochéms, C., Lagerquist, M. K., Forsblad‐d’Elia, H., & Carlsten, H. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.05.018 · Cited by 148
Receptor Activator of NF-κB Ligand Induction via Jak2 and Stat5a in Mammary Epithelial Cells
Srivastava, S., Matsuda, M., Hou, Z., Bailey, J. P., Kitazawa, R., Herbst, M. P., & Horseman, N. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308545200 · Cited by 125
Mechanical strain inhibits expression of osteoclast differentiation factor by murine stromal cells
Rubin, J., Murphy, T., Nanes, M. S., & Fan, X. (2000) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2000.278.6.c1126 · Cited by 138
Chen, L., Wei, X., Evans, B. A. J., Jiang, W. G., & Aeschlimann, D. P. (2008) · European Journal of Immunology · doi:10.1002/eji.200838192 · Cited by 147
Estrogen deficiency, T cells and bone loss
Pacifici, R. (2008) · Cellular Immunology · doi:10.1016/j.cellimm.2007.06.008 · Cited by 146
Dempster, D. W., Lambing, C. L., Kostenuik, P. J., & Grauer, A. (2012) · Clinical Therapeutics · doi:10.1016/j.clinthera.2012.02.002 · Cited by 146
Childs, L. M., Paschalis, E. P., Xing, L., Dougall, W. C., Anderson, D., Boskey, A. L., Puzas, J. E., Rosier, R. N., O'Keefe, R. J., Boyce, B. F., et al. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.2.192 · Cited by 146
Self-citationHotokezaka, H., Sakai, E., Ohara, N., Hotokezaka, Y., Gonzales, C., Matsuo, K., Fujimura, Y., Yoshida, N., & Nakayama, K. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21167 · Cited by 136
Kojima, T., Morikawa, Y., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., Senba, E., & Kitamura, T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002691200 · Cited by 133
Heemstra, K. A., Hamdy, N. A. T., Romijn, J. A., & Smit, J. W. A. (2006) · Thyroid · doi:10.1089/thy.2006.16.583 · Cited by 134
Clinical development of anti-RANKL therapy
Schwarz, E. M., & Ritchlin, C. T. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2171 · Cited by 145
Takegahara, N., Kim, H., & Choi, Y. (2022) · Bone · doi:10.1016/j.bone.2022.116353 · Cited by 143
Pathophysiological roles of osteoprotegerin (OPG)
Reid, P., & Holen, I. (2008) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2008.06.004 · Cited by 143
Kubota, K., Sakikawa, C., Katsumata, M., Nakamura, T., & Wakabayashi, K. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.2.257 · Cited by 130
Characterization of osteoclast precursors in human blood
Shalhoub, V., Elliott, G., Chiu, L., Manoukian, R., Kelley, M., Hawkins, N., Davy, E., Shimamoto, G., Beck, J., Kaufman, S. A., et al. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02379.x · Cited by 131
Watanabe, T., Kukita, T., Kukita, A., Wada, N., Toh, K., Nagata, K., Nomiyama, H., & Iijima, T. (2004) · Journal of Endocrinology · doi:10.1677/joe.0.1800193 · Cited by 143
Mikkola, M. L., Pispa, J., Pekkanen, M., Paulin, L. G., Nieminen, P., Kere, J., & Thesleff, I. (1999) · Mechanisms of Development · doi:10.1016/s0925-4773(99)00180-x · Cited by 143
Regulation of Vascular Inflammation and Remodeling by ETS Factors
Oettgen, P. (2006) · Circulation Research · doi:10.1161/01.res.0000251056.85990.db · Cited by 142
Ogasawara, T., Yoshimine, Y., Kiyoshima, T., Kobayashi, I., Matsuo, K., Akamine, A. A., & Sakai, H. (2003) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.2004.00699.x · Cited by 142
RANK ligand is a prerequisite for cancer-associated osteolytic lesions.
Kitazawa, S., & Kitazawa, R. (2002) · The Journal of Pathology · doi:10.1002/path.1199 · Cited by 141
“Recently osteoclast differentiation factor (ODF) [8] or osteoprotegerin ligand (OPGL) [9], identical to the receptor activator of nuclear factor-κB ligand (RANKL) [10], has been isolated and identified as a prerequisite for the formation and maintenance of osteoclasts [11,12].”
BackgroundKostenuik, P. J., Capparelli, C., Morony, S., Adamu, S., Shimamoto, G., Shen, V., Lacey, D. L., & Dunstan, C. R. (2001) · Endocrinology · doi:10.1210/endo.142.10.8437 · Cited by 140
“By blocking OPGL/RANKL-induced RANK activation, OPG inhibits osteoclast differentiation, activation, and survival (35).”
InfluentialThe anti-tumor effect of RANKL inhibition in malignant solid tumors – A systematic review
de Groot, A. F., Appelman‐Dijkstra, N. M., van der Burg, S. H., & Kroep, J. R. (2017) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2017.10.010 · Cited by 140
Gonzalez-Suarez, E., Branstetter, D., Armstrong, A., Dinh, H., Blumberg, H., & Dougall, W. C. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01298-06 · Cited by 129
Self-citationFeng, W., Li, W., Liu, W., Wang, F., Li, Y., & Yan, W. (2009) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2009.06.001 · Cited by 139
Watts, N. B., Roux, C., Modlin, J. F., Brown, J. P., Daniels, A., Jackson, S., Smith, S., Zack, D. J., Zhou, L., Grauer, A., et al. (2012) · Osteoporosis International · doi:10.1007/s00198-011-1755-2 · Cited by 135
The Role of RANK-Ligand Inhibition in Cancer: The Story of Denosumab
Castellano, D., Sepúlveda-Sánchez, J. M., García-Escobar, I., Rodríguez-Antolín, A., Sundlöv, A., & Cortés-Funes, H. (2011) · The Oncologist · doi:10.1634/theoncologist.2010-0154 · Cited by 138
The molecular mechanism of osteoclastogenesis in rheumatoid arthritis.
Udagawa, N., Kotake, S., Kamatani, N., Takahashi, N., & Suda, T. (2002) · Arthritis Research · doi:10.1186/ar431 · Cited by 138
Hofbauer, L. C. (1999) · European Journal of Endocrinology · doi:10.1530/eje.0.1410195 · Cited by 138
Inada, M., Matsumoto, C., Uematsu, S., Akira, S., & Miyaura, C. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.3.1879 · Cited by 129
Aoki, K., Saito, H., Itzstein, C., Ishiguro, M., Shibata, T., Blanque, R., Mian, A. H., Takahashi, M., Suzuki, Y., Yoshimatsu, M., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci22513 · Cited by 136
Receptor Activator of NF-κB Ligand Regulates the Proliferation of Mammary Epithelial Cells via Id2
Kim, N.-S., Kim, H.-J., Koo, B.-K., Kwon, M.-C., Kim, Y.-W., Cho, Y., Yokota, Y., Penninger, J. M., & Kong, Y.-Y. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.3.1002-1013.2006 · Cited by 110
Kim, H.-H., Lee, D. E., Shin, J. N., Lee, Y. S., Jeon, Y. M., Chung, C.-H., Ni, J., Kwon, B. S., & Lee, Z. H. (1999) · FEBS Letters · doi:10.1016/s0014-5793(98)01731-1 · Cited by 125
Kim, Y.-M., Kim, Y.-M., Lee, Y. M., Kim, H.-S., Kim, J. D., Choi, Y., Kim, K.-W., Lee, S.-Y., & Kwon, Y.-G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109434200 · Cited by 125
Shalhoub, V., Faust, J., Boyle, W. J., Dunstan, C. R., Kelley, M., Kaufman, S., Scully, S., Van, G., & Lacey, D. L. (1999) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19990201)72:2<251::aid-jcb9>3.0.co;2-w · Cited by 123
Onyia, J. E., Miles, R. R., Yang, X., Halladay, D. L., Hale, J., Glasebrook, A., McClure, D., Seno, G., Churgay, L., Chandrasekhar, S., et al. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.5.863 · Cited by 127
Cutting Edge Commentary: Immune Responses in the Absence of Costimulation: Viruses Know the Trick
Bachmann, M. F., Zinkernagel, R. M., & Oxenius, A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.11.5791 · Cited by 137
Kobayashi, Y., Hashimoto, F., Miyamoto, H., Kanaoka, K., Miyazaki-Kawashita, Y., Nakashima, T., Shibata, M., Kobayashi, K., Kato, Y., & Sakai, H. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.10.1924 · Cited by 136
Min, J.-K., Kim, Y.-M., Kim, Y.-M., Kim, E.-C., Gho, Y. S., Kang, I.-J., Lee, S.-Y., Kong, Y.-Y., & Kwon, Y.-G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300539200 · Cited by 118
Death to the bad guys: Targeting cancer via Apo2L/TRAIL
Bouralexis, S., Findlay, D. M., & Evdokiou, A. (2005) · APOPTOSIS · doi:10.1007/s10495-005-6060-0 · Cited by 136
Holding, C. A., Findlay, D. M., Stamenkov, R. B., Neale, S. D., Lucas, H., Dharmapatni, A. A. S. K., Callary, S. A., Shrestha, K. R., Atkins, G. J., Howie, D. W., et al. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.05.054 · Cited by 136
Receptor Activator of Nuclear Factor-κB Ligand Activates Nuclear Factor-κB in Osteoclast Precursors*
Wei, S., Teitelbaum, S. L., Wang, M. W.-H., & Ross, F. P. (2001) · Endocrinology · doi:10.1210/endo.142.3.8031 · Cited by 122
Schlöndorff, J., Lum, L., & Blobel, C. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010741200 · Cited by 130
APRIL/TRDL-1, a tumor necrosis factor-like ligand, stimulates cell death.
Kelly, K., Manos, E. J., Jensen, G. S., Nadauld, L. D., & Jones, D. A. (2000) · PubMed · Cited by 135
Smedt, T. D., Pajak, B., Klaus, G. G. B., Noelle, R. J., Urbain, J., Léo, O., & Moser, M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.9.4476 · Cited by 135
Role of carotenoid beta-cryptoxanthin in bone homeostasis
Yamaguchi, M. (2012) · Journal of Biomedical Science · doi:10.1186/1423-0127-19-36 · Cited by 134
Van Wesenbeeck, L., Odgren, P. R., MacKay, C. A., D'Angelo, M., Safadi, F. F., Popoff, S. N., Van Hul, W., & Marks, S. C. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202332999 · Cited by 123
Imbalance of RANKL/RANK/OPG system in interface tissue in loosening of total hip replacement
Mandelin, J. M., Li, T.-F., Liljeström, M., Kroon, M. E., Hanemaaijer, R., Santavirta, S. S., & Konttinen, Y. T. (2003) · Journal of Bone and Joint Surgery - British Volume · doi:10.1302/0301-620x.85b8.13311 · Cited by 134
Kaneda, T., Nojima, T., Nakagawa, M., Ogasawara, A., Kaneko, H., Sato, T., Mano, H., Kumegawa, M., & Hakeda, Y. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.8.4254 · Cited by 119
Catalytic Properties of ADAM19
Chesneau, V., Becherer, J. D., Zheng, Y., Erdjument-Bromage, H., Tempst, P., & Blobel, C. P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302781200 · Cited by 129
Parathyroid Hormone-induced Bone Resorption Does Not Occur in the Absence of Osteopontin
Ihara, H., Denhardt, D. T., Furuya, K., Yamashita, T., Muguruma, Y., Tsuji, K., Hruska, K. A., Higashio, K., Enomoto, S., Nifuji, A., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010938200 · Cited by 122
p53-dependent impairment of T-cell proliferation in FADD dominant-negative transgenic mice
Zörnig, M., Hueber, A., & Evan, G. I. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70182-4 · Cited by 134
Generation and culture of osteoclasts
Marino, S., Logan, J. G., Mellis, D., & Capulli, M. (2014) · BoneKEy Reports · doi:10.1038/bonekey.2014.65 · Cited by 115
Zhu, J. J., Ramanathan, P., Bishop, E. A., O’Donnell, V. K., Gladue, D. P., & Borca, M. V. (2019) · PLoS ONE · doi:10.1371/journal.pone.0223955 · Cited by 133
Page, G., & Miossec, P. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21211 · Cited by 121
Yamada, Y. M. A., Fujimoto, A., Itô, A., Yoshimi, R., & Ueda, M. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.02.009 · Cited by 133
Osteoprotegerin: a link between osteoporosis and arterial calcification?
Hofbauer, L. C., & Schoppet, M. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05494-0 · Cited by 133
Pathophysiology of bone cancer pain.
Sabino, M. A. C., & Mantyh, P. W. (2005) · PubMed · Cited by 132
Molecular Mechanism of the Bifunctional Role of Lipopolysaccharide in Osteoclastogenesis
Liu, J., Wang, S., Zhang, P., Said-Al-Naief, N., Michalek, S. M., & Feng, X. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809789200 · Cited by 126
Fazzalari, N. L., Kuliwaba, J. S., Atkins, G. J., Forwood, M. R., & Findlay, D. M. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.6.1015 · Cited by 129
“(9,10) Recently, a cell-surface member of the tumor necrosis factor (TNF) ligand family, termed receptor activator of nuclear factor kB ligand (RANKL),((11)) or variously termed TNF-related activation-induced cytokine osteoprotegerin ligand/osteoclast differentiation factor (TRANCE((12))/OPGL((13))/ODF((14))) was show…”
BackgroundThe immune system, bone and RANKL
Guerrini, M. M., & Takayanagi, H. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.06.003 · Cited by 129
The RANKL/OPG system and bone mineral density in patients with chronic liver disease
Moschen, A. R., Kaser, A., Stadlmann, S., Millonig, G., Kaser, S., Mühllechner, P., Habior, A., Graziadei, I. W., Vogel, W., & Tilg, H. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.05.034 · Cited by 129
Zauli, G., Rimondi, E., Nicolin, V., Melloni, E., Celeghini, C., & Secchiero, P. (2004) · Blood · doi:10.1182/blood-2004-03-1196 · Cited by 113
Oyajobi, B. O., Anderson, D. M., Traianedes, K., Williams, P. J., Yoneda, T., & Mundy, G. R. (2001) · PubMed · Cited by 128
Self-citationPathophysiological mechanisms of root resorption after dental trauma: a systematic scoping review
Galler, K. M., Grätz, E.-M., Widbiller, M., Buchalla, W., & Knüttel, H. (2021) · BMC Oral Health · doi:10.1186/s12903-021-01510-6 · Cited by 127
Emerging Applications of the Tumor Necrosis Factor Family of Ligands and Receptors in Cancer Therapy
Younes, A., & Kadin, M. E. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.09.037 · Cited by 127
Rankl-induced osteoclastogenesis leads to loss of mineralization in a medaka osteoporosis model
To, T. T., Witten, P. E., Renn, J., Bhattacharya, D., Huysseune, A., & Winkler, C. (2011) · Development · doi:10.1242/dev.071035 · Cited by 126
The Alternative Faces of Macrophage Generate Osteoclasts
Lampiasi, N., Russo, R., & Zito, F. (2016) · BioMed Research International · doi:10.1155/2016/9089610 · Cited by 108
Ohshiba, T., Miyaura, C., Inada, M., & Itô, A. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600858 · Cited by 126
Regulation of osteoclastogenesis and RANK expression by TGF‐β1
Yan, T., Riggs, B. L., Boyle, W. J., & Khosla, S. (2001) · Journal of Cellular Biochemistry · doi:10.1002/jcb.1200 · Cited by 109
RANK (receptor activator of nuclear factor-κB) and RANKL expression in multiple myeloma.
Roux, S., Meignin, V., Quillard, J., Meduri, G., Guiochon‐Mantel, A., Fermand, J., Milgrom, E., & Mariette, X. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03417.x · Cited by 125
“In addition to their role in the bone remodelling process, interactions between RANKL expressed on T cells and RANK expressed on dendritic cells have been involved in anti-apoptotic pathways, leading to an increased survival of dendritic cells (Anderson et al, 1997; Wong et al, 1997).”
Background
Metadata
- Authors
- Anderson, D. M., Maraskovsky, E., Billingsley, W. L., Dougall, W. C., Tometsko, M. E., Roux, E. R., Teepe, M. C., DuBose, R. F., Cosman, D., & Galibert, L.
- Corresponding author
- Anderson, Dirk M.
- Venue
- Nature
- Published
- 1997-11
- Volume
- 390
- Issue
- 6656
- Pages
- 175-179
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1650001464
- Cited by
- 2,290
- References
- 30
- Citations by year
- 2026: 31 · 2025: 32 · 2024: 37 · 2023: 45 · 2022: 53 · 2021: 79 · 2020: 74 · 2019: 63 · 2018: 56 · 2017: 71 · 2016: 53 · 2015: 73 · 2014: 80 · 2013: 83 · 2012: 94
- FWCI
- 37.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- RANK, RANK ligand, TNF receptor superfamily, dendritic cells, T cell proliferation, T cell survival, antigen presentation, immune regulation, IL-4, TGF-beta, mixed lymphocyte reaction
- MeSH terms
- Amino Acid Sequence, Animals, Carrier Proteins, Cell Line, Cells, Cultured, Chromosome Mapping, Chromosomes, Human, Pair 13, Chromosomes, Human, Pair 18, Dendritic Cells, Humans, Ligands, Membrane Glycoproteins, Membrane Proteins, Molecular Sequence Data, T-Lymphocytes, Transfection, Sequence Homology, Amino Acid, Receptors, Tumor Necrosis Factor, CD40 Ligand, Mice, RANK Ligand, Receptor Activator of Nuclear Factor-kappa B
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.